Long non-coding RNA GRASLND affects melanoma phenotypic switch and modulates immunogenicity by inhibition of the IFNγ signaling pathway (IFNg treatment and GRASLND KD).
RNA-seq (gene expression) · human · 12 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 12 samples: 6 conditions, mostly in duplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Long non-coding RNA GRASLND links melanoma differentiation and interferon-gamma responseFrontiers in molecular biosciences · 2024
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE273020_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1139801 and SRA study SRP522114. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 12 samples.
How we read this: 6 replicated groups read from 12 sample titles; they account for 12 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8417069 501Mel, shlacZ, IFNγ-treated, uninduced, Rep1 501Mel, shlacZ, IFNγ-tr…
- GSM8417070 501Mel, shlacZ, IFNγ-treated, uninduced, Rep2 501Mel, shlacZ, IFNγ-tr…
- GSM8417071 501Mel, shlacZ, IFNγ-treated, dox-induced, Rep1 501Mel, shlacZ, IFNγ-tr…
- GSM8417072 501Mel, shlacZ, IFNγ-treated, dox-induced, Rep2 501Mel, shlacZ, IFNγ-tr…
- GSM8417073 501Mel, sh4, IFNγ-treated, uninduced, Rep1 501Mel, sh4, IFNγ-treat…
- GSM8417074 501Mel, sh4, IFNγ-treated, uninduced, Rep2 501Mel, sh4, IFNγ-treat…
- GSM8417075 501Mel, sh4, IFNγ-treated, dox-induced, Rep1 501Mel, sh4, IFNγ-treat…
- GSM8417076 501Mel, sh4, IFNγ-treated, dox-induced, Rep2 501Mel, sh4, IFNγ-treat…
- GSM8417077 501Mel, sh8, IFNγ-treated, uninduced, Rep1 501Mel, sh8, IFNγ-treat…
- GSM8417078 501Mel, sh8, IFNγ-treated, uninduced, Rep2 501Mel, sh8, IFNγ-treat…
- GSM8417079 501Mel, sh8, IFNγ-treated, dox-induced, Rep1 501Mel, sh8, IFNγ-treat…
- GSM8417080 501Mel, sh8, IFNγ-treated, dox-induced, Rep2 501Mel, sh8, IFNγ-treat…
- GSE255658 Effects of lipopolysaccharide (LPS) or interferon gamma (IFNy) treatment on wild type or PILRA knock-out iPSC-derived human microglia after 24 hours 30 samples shares ifn, treatment
- GSE324785 Comparative analysis of gene expression in HDV-infected dHepaRG cells upon treatment with IFN-α-2a or IFN-λ1 27 samples shares ifn, treatment
- GSE254537 Inhibition of CXCL10 and IFN-γ ameliorates myocarditis in preclinical models of SARS-CoV- 2 mRNA vaccination 24 samples shares ifn, inhibition
- GSE301269 Comparison of expression profiles of Control and CDDO-Im treatment microglia under IFN-gamma or Amyloid beta stimulation 24 samples shares ifn, treatment
- GSE273022 Long non-coding RNA GRASLND links melanoma differentiation and interferon-gamma response 19 samples shares graslnd, non-coding
- GSE298341 ISG15-Mediated Suppression of Type I Interferon Signaling Leads to Susceptibility to Epstein-Barr Virus Infection (LCL_IFN_treatment_BulkRNAseq) 18 samples shares ifn, treatment
- GSE314089 Uncoupling the two distinct roles of targeting BDCA2 in treating autoimmune diseases: direct inhibition of BDCA2-positive B cells and normalization of proinflammatory monocyte-derived macrophages via the global suppression of type I IFN 16 samples shares ifn, inhibition
- GSE269453 Differential gene expression in SK-MEL-5 and MALME-3M cell lines following IFN-γ treatment 12 samples shares ifn, treatment
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.